Vertex currently operates at the forefront of rare disease scientific innovation and has successfully developed and commercialized multiple breakthrough medicines for Cystic Fibrosis (CF). In addition to clinical development programs in CF, Vertex has more than a dozen ongoing research programs focused on the underlying mechanisms of other serious diseases including programs in pain, hemoglobinopathies, focal segmental glomerulosclerosis (FSGS) and Alpha-1 Antitrypsin Deficiency (AAT), among others.
In consideration of our expanding pipeline and an increasingly complex and challenging Global market access environment, Vertex is expanding its Global Pricing & Market Access (GPMA) team. Our focus is to extend our expertise in this functional area in order to deliver impactful market access strategies and contextualize the rapidly evolving healthcare landscape for the pricing and reimbursement of Vertex therapies. We are driven by a desire to deliver groundbreaking pricing & reimbursement solutions to allow our medicines to reach patients faster than ever before.
The Associate Director / Director, GPMA role will join the Non-CF Pipeline team within GPMA and serve as Market Access Lead for our Hemoglobinopathy gene therapy programs. These programs are part of our collaboration with CRISPR Therapeutics for the treatment of hemoglobinopathies, including β-thalassemia and sickle cell disease. In this capacity, the individual will be responsible for leading the development of Global Market Access strategies, as well as co-lead for the Global Commercial Team. This role will also support initiatives within the Non-CF Pipeline team as needed including business development initiatives. This position reports to the Senior Director, Non-CF Pipeline, within GPMA, and is a member of the Global Market Access & Value (GMAV) organization.
- Responsible for Global payer strategic planning to support value and access optimization for gene therapies in development for Hemoglobinopathies
- Lead development of Market Access strategies and core Global P&R deliverables operating within the cross-functional, cross-regional commercialization process
- Ensure the payer position is consistently represented to internal stakeholders and ensure robust strategic input into commercialization and development decisions
- Support strategies with deep functional knowledge, in-depth market research, environmental data & analogs
- Inform financial forecasts
- Partner with HEOR and Global Marketing to ensure robust value proposition and integrated evidence plans are optimized to support global market access and reimbursement
- Co-lead Global Commercial Team (with Global Marketing) for Hemoglobinopathy programs, and work cross-functionally to develop optimal commercial and market access strategies
- Develop market access strategy including robust payer landscape, initial pricing assumptions
- Partner with HEOR and Global Marketing to ensure development of a robust value proposition and supporting value story
- Lead capability building and thought leadership projects that advance knowledge of and readiness for the rapidly evolving Global payer environment.
- The individual in this role is expected to be the internal thought leader on payer-related aspects of the funding, pricing, and access for gene therapies
- Support payer pricing & access assumptions for business development and emerging pipeline opportunities
- Collaborate closely with HEOR, International P&R, Corporate Affairs, US Managed Markets, Countries, Marketing and Clinical Development counterparts to ensure value and access optimization
- 7+ years of direct biotechnology / pharmaceutical industry experience and/or payer experience
- Experience developing Global payer strategies for one-time/curative treatments preferred (e.g., gene therapies) at a biotechnology / pharmaceutical company
- Experience in comparable Global role considered a plus; deep working knowledge of both US and ex-US healthcare systems required
- Demonstrated ability to think strategically and make sound pricing and market access recommendations
- Strong practical, quantitative and analytical skills combined with a sound understanding of how to successfully apply pricing & reimbursement / HEOR principles to support Vertex
- General experience in commercialization and drug development
- Exhibits outstanding written and oral communication skills, including the ability to effectively write and deliver presentations to professionals at all levels within Vertex
- Demonstrated relationship building at all levels of the organization and across geographies
- Recognized as a team player with excellent interpersonal skills who is flexible and reliable
- Displays sound ethics and a fit for Vertex’s core values
#LI-SL1* The salary listed in the header is an estimate based on salary data for similar jobs in the same area. Salary or compensation data found in the job description is accurate.
- BA in field of study requiring quantitative analysis; advanced degree preferred
Loading some great jobs for you...